Fenix Health Science and the Emerging Market for Precision Cognitive Nutrition
The global supplement industry has expanded rapidly over the past decade, particularly in areas related to cognitive health and emotional regulation. Within this crowded field, some companies are focusing on more targeted formulations grounded in biochemical research rather than broad, general wellness products. One example is Fenix Health Science, a Fort Worth, Texas–based company founded in 2018 that develops nutritional supplements and diagnostic tools designed to support brain function in children and adults.
The company markets its products primarily under the Accentrate® brand. These products are structured as a modular system of supplements that provide what the company describes as nutritional “building blocks” for the brain. Rather than offering a single all-in-one supplement, the system separates key nutrients into specialized collections such as omega-3 formulations, active vitamin complexes, and mineral blends.
Fenix Health Science operates in a niche segment that connects nutrition, neuroscience, and personalized health. The brand’s strategy reflects broader industry trends toward targeted supplementation, genetic testing, and individualized treatment approaches. Its products are marketed to parents, adults interested in cognitive health, and medical professionals who use nutritional support alongside traditional treatments.
One of the central features of the Fenix Health Science product ecosystem is its use of Lysoveta™, a specialized form of omega-3 fatty acid known as lysophosphatidylcholine (LPC). The company positions this ingredient as a key differentiator in a supplement category dominated by standard fish oil products.
Scientific research has long highlighted the importance of omega-3 fatty acids in brain function. Neurologist David Perlmutter, MD, notes that “DHA represents over 90% of all the omega-3 polyunsaturated fatty acids in the brain, and further, it’s 10 to 20% of all the brain’s fat” (Perlmutter, 2013). Because of this high concentration, effective delivery of DHA to brain tissue is often considered an important factor in cognitive health research.
Lysoveta™ is designed to interact with the MFSD2A receptor, a transporter that regulates how certain lipids cross the blood-brain barrier. According to the company, this mechanism allows the LPC form of omega-3 to reach the brain more efficiently than conventional fish oil supplements (Aker BioMarine, 2023).
This formulation appears in the Accentrate® Omega collection, which includes products such as Omega, Omega 110, and Omega Max. The formulations are typically separated into versions for individuals under and over 110 pounds, reflecting the company’s effort to tailor dosing to body weight.
Research into omega-3 supplementation continues to evolve. A review from GrassrootsHealth reported that omega-3 fatty acids EPA and DHA have been associated with improvements in cognitive performance, attention, and processing speed, while DHA in particular has been linked to memory function (GrassrootsHealth, n.d.).
Another notable aspect of the company’s model is its integration of diagnostic tools with supplement recommendations. Fenix Health Science offers genetic tests that examine specific polymorphisms related to nutrient metabolism and neurological risk factors.
Two examples include testing for the APOE4 allele and the MTHFR gene variant. The APOE4 allele has been associated with an increased risk of Alzheimer’s disease and may influence how the body processes certain lipids, including DHA. Individuals who carry the allele may metabolize omega-3 fatty acids differently from those without the genetic variant.
The MTHFR gene test focuses on polymorphisms that affect how the body converts folate and related B vitamins into their active forms. Some individuals with these variations have difficulty processing synthetic folic acid, which has led to increased interest in supplements containing activated forms of B vitamins.
Fenix Health Science integrates these insights into its Neuro collection of supplements, which includes active forms of vitamins such as B6, B12, and vitamin D. According to research cited in meta-analyses of ADHD studies, vitamin D supplementation has been associated with decreased symptoms of hyperactivity and inattention in some children (Oregon Health & Science University, n.d.).
The company also provides an online nutrition quiz that guides users through symptom-based questions to recommend combinations of products suited to individual needs. This reflects a growing trend in the supplement industry toward personalized nutrition rather than standardized formulas.
The Accentrate® product line is structured around a modular system that separates nutritional components into several categories. These include omega-3 supplements, vitamin formulations, mineral blends, and probiotic products designed to support the gut-brain axis.
The Minerals collection contains chelated forms of magnesium, zinc, and iron. Chelated minerals are commonly used in nutritional supplements because they may be more easily absorbed by the body compared with some inorganic mineral forms.
The probiotic formula in the product ecosystem focuses on strains that have been studied in relation to mood and cognitive function. Research on the gut-brain axis has expanded significantly in recent years, with scientists examining how microbial populations in the digestive system may influence neurological signaling.
The company’s supplements are typically used as adjunctive support rather than replacements for medical treatment. Researchers at Oregon Health & Science University have noted that “there is sufficient evidence to consider omega-3 fatty acids as a possible supplement to established therapies” for conditions such as ADHD (Oregon Health & Science University, n.d.).
More information about the company’s supplement system and diagnostic tools can be found on its official website at https://www.fenixhealthscience.com/.
Fenix Health Science has also focused on research collaborations and regulatory approvals related to its key ingredients. One notable milestone occurred in August 2023 when the U.S. Food and Drug Administration approved the New Dietary Ingredient (NDI) submission for Lysoveta™, confirming the safety of the compound for use in supplements (U.S. Food and Drug Administration, 2023).
The ingredient was developed through a partnership with Aker BioMarine, a global supplier of krill-derived nutrients. According to company information, the development of Lysoveta™ involved approximately a decade of research and development before reaching the consumer market (Aker BioMarine, 2023).
The company has also moved toward fully domestic manufacturing. Production was shifted to facilities within the United States after previous supply chain challenges involving international shipping and customs inspections. This change was intended to improve supply reliability and regulatory oversight.
Fenix Health Science distributes its products primarily through its direct-to-consumer website and online retail platforms such as Amazon. The brand has reported periods of rapid digital growth, including a surge in web traffic following a widely viewed educational video discussing its ingredients in early 2025.
Interest in brain health supplements continues to rise as research explores the links between nutrition, genetics, and neurological function. Companies operating in this space increasingly focus on targeted formulations and data-driven recommendations rather than generalized wellness products.
Fenix Health Science represents one example of this shift. By combining specialized omega-3 delivery systems, active nutrient formulations, and genetic testing tools, the company aims to address specific biological pathways related to cognitive performance and emotional regulation.
The broader market for cognitive nutrition is likely to continue evolving alongside advances in neuroscience and personalized medicine. As research progresses, companies that integrate biochemical insights with accessible consumer products may play a growing role in how individuals approach long-term brain health.
Bartel, B. (2018). Founding of Fenix Health Science and the development of Accentrate® supplements. Fenix Health Science.
Fenix Health Science. (2024). Accentrate® product collections: Omega, Neuro, Minerals, and Probiotic formulations. Retrieved from https://www.fenixhealthscience.com/
Fenix Health Science. (2023). Lysoveta™ New Dietary Ingredient (NDI) approval and ingredient safety documentation. U.S. Food and Drug Administration.
GrassrootsHealth. (n.d.). Research review on omega-3 fatty acids and cognitive performance. GrassrootsHealth Nutrient Research Institute.
Oregon Health & Science University. (n.d.). Evidence for omega-3 fatty acids as a supplement to established ADHD therapies.
Perlmutter, D. (2013). Grain Brain: The surprising truth about wheat, carbs, and sugar—your brain’s silent killers. Little, Brown and Company.
U.S. Food and Drug Administration. (2023). New Dietary Ingredient notification for Lysoveta™.
Aker BioMarine. (2023). Research and development partnership for Lysoveta™ omega-3 lipid delivery technology.
In 2026, sustainability is no longer a trend—it’s a necessity. Climate change, pollution, and resource depletion are pushing businesses to…
Technology is transforming education at an unprecedented pace. In 2026, the shift toward digital learning ecosystems, artificial intelligence, and skill-based…
The electrical industry serves a wide range of environments, from single-family homes to large commercial facilities. While both residential and…
Starting a tree service business can be a lucrative endeavor, especially given the current market trends and demands. With an…
In the modern quest for energy efficiency, homes have become increasingly sealed against the elements. While this leads to savings…
Mental health is an integral part of overall well-being, but it is often neglected when compared to physical ailments. Preventive…